Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 Vaccine in Healthy Adults

NCT04566276 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT04566276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04566276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 Vaccine in Healthy Adults
Lead sponsor
Chulalongkorn University
Phase
Phase 1/2
Overall status
Completed
Start date
May 3, 2021
Completion date
December 6, 2022
Enrollment
192 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccine, safety issues